SAR-100842: Clinical Trials

1 trial of SAR-100842, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow SAR-100842: new trials by email Literature Review of SAR-100842 trials Research Report on SAR-100842

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Proof of Biological Activity of SAR100842 in Systemic Sclerosis
SAR100842, Placebo (for SAR100842) - Systemic Sclerosis
Phase 2CompletedSanofi322013-01-012016-03-25

Conditions studied

Scleroderma, Systemic (1)

Sponsors

Sanofi (1)

Countries

France (1)  ·  Italy (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 29732731